Hemoglobin A1c Testing is Recommended
You should order a hemoglobin A1c (option a) for this patient before her ankle surgery. 1
Rationale for HbA1c Testing
The 2024 AHA/ACC guideline explicitly states: "If not obtained within 3 months of noncardiac surgery, it is reasonable to check the preoperative hemoglobin A1c before surgery." 1 Since this patient's last HbA1c was measured 5 months ago (exceeding the 3-month window), repeat testing is indicated.
Key Clinical Considerations:
- Her diabetes is well-controlled (previous HbA1c 6.8%), but verification is needed to ensure glycemic status hasn't changed
- The guideline notes that while there are no validated HbA1c risk thresholds, it may be reasonable to postpone elective surgery if HbA1c is higher than 8% 1
- For this elective ankle surgery, knowing current glycemic control helps optimize perioperative glucose management
- Preoperative glucose control directly impacts surgical outcomes, with glucose ≥200 mg/dL associated with >2-fold higher all-cause mortality 1
Why Not the Other Tests?
PT/INR (option b): Not Indicated
- Metformin does not affect coagulation 2
- PT/INR testing is reserved for patients on anticoagulants or with known bleeding disorders
- While diabetes can affect coagulation parameters, routine PT/INR screening is not recommended for uncomplicated diabetic patients on metformin alone
Echocardiogram (option c): Not Indicated
- No clinical indication for routine echocardiography in this asymptomatic patient
- Reserved for patients with known cardiac disease, symptoms, or specific risk stratification needs
- This patient has no mentioned cardiac symptoms or history
Cardiac Troponin (option d): Not Indicated for Routine Screening
- While emerging evidence suggests troponin may identify subclinical heart failure in diabetics 3, routine troponin screening is not currently recommended in asymptomatic patients undergoing low-to-moderate risk surgery
- Troponin elevation would be relevant if there were cardiac symptoms or high-risk features, which are absent here
Perioperative Metformin Management
Continue metformin perioperatively. The guideline explicitly states: "more recent data suggest that metformin is not associated with lactic acidosis" and references a study of >10,600 patients showing no association between metformin use and lactic acidosis risk 1. The FDA label's historical concerns about lactic acidosis 2 have been superseded by contemporary evidence supporting continuation in stable patients.
Common Pitfall to Avoid:
Do not unnecessarily discontinue metformin based on outdated concerns about perioperative lactic acidosis. The evidence shows metformin continuation is safe and may actually reduce complications 4.